Concepedia

Publication | Closed Access

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial

55

Citations

14

References

2014

Year

References

YearCitations

Page 1